Asia-Pacific accounts for close to one-third of global OTC sales, says expert

13 August 2014

Return to Media Release Index

13 August 2014  - The Australian Self Medication Industry (ASMI) today announced that Nicholas Hall, an internationally recognised expert in the non-prescription medicines industry, will discuss Global OTC Trends, Insights and Future Drivers at the ASMI 2014 Conference on 18 November 2014.

ASMI Executive Director Deon Schoombie said that: "Nicholas will focus on emerging trends in the global and regional OTC market, and how multinational and Asia-Pacific players can learn from international best practice, as well as create their own business models and success strategies.

"Nicholas will be sharing vital information including the latest research findings and insights gained from 40 years of working with top OTC players globally," said Schoombie.
A recent study completed by Nicholas Hall Group and Nielsen explored self-medication trends in four South East Asian markets (Indonesia, Philippines, Thailand and Vietnam). The report described the emergence of a new consumer class in South East Asia who are sophisticated and discerning.

Figures published by Nicholas Hall & Co revealed that sales of OTC medicines in Asia-Pacific reached US$40 billion in 2013, representing close to one-third of global OTC sales (32.0%). The Asia-Pacific region experienced growth of 4.5 percent in 2013, compared to 4.7 percent globally. This weakened performance was mainly because of slower growth in China and India while Japan continued to stagnate.
The Nicholas Hall Group of Companies (NHC) was established 36 years ago and is now the leading independent marketing consultancy and business intelligence network specialising in consumer healthcare.

Nicholas Hall has more than 40 years' experience in packaged goods and Health and Beauty Aid (HBA) with Procter & Gamble and other blue chip players. He was responsible for the development of Olay when it was first acquired by Richardson‐Vicks, including its first‐ever TV campaign, retail sales force and trade marketing.


When: Tuesday 18 November 2014. Registration and coffee at 8.30 am

Where: Waterview Convention Centre, Sydney Olympic Park, Homebush, Sydney

Who: Delegates from all sectors of the non-prescription medicines industry are encouraged to attend

How: To register online click here

Contact: Claire Johnson, ASMI Member Events and Services Associate 02 9922 5111 |

About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy.

For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: